Pfizer Sells Off After Discontinuing Weight Loss Drug – The Wall Street Journal
Business News
- Pfizer Sells Off After Discontinuing Weight Loss Drug The Wall Street Journal
- Pfizer stock drops as it ends development of Ozempic rival Yahoo Finance
- Pfizer stock drops after company picks twice-daily weight loss pill candidate Yahoo Finance
- Pfizer drops oral obesity drug after seeing liver safety concern, focuses on less-convenient candidate FierceBiotech
- Pfizer Stock Tumbles On ‘A Big Setback’ In Obesity Treatment Investor’s Business Daily
- View Full Coverage on Google News
Source: Business News